1 Protagonist Therapeutics Inc Receivables Turnover Ratio (PTGX), from the third quarter 2026 to the third quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Protagonist Therapeutics inc   (NASDAQ: PTGX)
 

Protagonist Therapeutics Inc Accounts Receivables Turnover Ratio from the third quarter 2026 to the third quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Protagonist Therapeutics Inc 's ability to collect accounts receivable sequentially worsen to 6.29, indicating more challenging environment then in the second quarter 2026, but still, it is a far cry from any concerns. Protagonist Therapeutics Inc 's Accounts Receivable average collection period in the Sep 30 2026 quarter, has increased to 58 days, from 22 days, in the Jun 30 2026 quarter.

If we take a look into Healthcare sector 345 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2026 from 2545 to 3216.

What is Receivable Turnover Ratio?
What is Protagonist Therapeutics Inc Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PTGX Receivables Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Receivable Change 48576.67 % - - - -
Y / Y Revenue Change 5723.64 % 3749.17 % 99.03 % -95.64 % 0.79 %
Receivable Turnover Ratio (TTM) 6.29 16.64 5.45 261.45 1435.45
PTGX's Total Ranking # 3216 # 2545 # 10 # 2343 #
Accounts Receivable average collection period days 58 22 67 1 0
Seq. Receivable Change 2015.27 % -75 % 44249.59 % -79.25 % -
Seq. Revenue Change 28.54 % 278.72 % 657.94 % 57.83 % -15.04 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 99
Healthcare Sector # 346
Overall Market # 3216

Receivable Turnover Ratio Statistics
High Average Low
0.67 0.19 -0
(Dec 31 2024)  





PTGX Company Profile • Back to PTGX Efficiency Comparisons • Compare PTGX Receivables Turnover Ratio to its Competitors

Financial Statements
Protagonist Therapeutics Inc 's Accounts Receivable $ 284 Millions Visit PTGX's Balance sheet
Protagonist Therapeutics Inc 's Sales TTM $ 552 Millions Visit PTGX's Income Statement
Sources of PTGX's Revenues Visit PTGX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
PTGX's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
PTGX's Growth Rates PTGX's Roa PTGX's Inventory Turnover Ratio PTGX's Dividend Comparisons
PTGX's Profitability Ratios PTGX's Roi PTGX's Asset Turnover Ratio PTGX's Dividend Growth
PTGX's Valuation Ratios PTGX's Roe PTGX's Financial Strength Ratios PTGX's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2026 Receivable at quarter ending Sep 30 2026
Ptc Therapeutics inc   5.26 $ 1,155.554  Millions$ 219.663  Millions
Repligen Corp  5.21 $ 805.610  Millions$ 154.771  Millions
Biomerica Inc   5.17 $ 4.338  Millions$ 0.838  Millions
Indivior Pharmaceuticals Inc   5.14 $ 1,376.000  Millions$ 267.500  Millions
Ge Healthcare Technologies Inc   5.11 $ 19,878.000  Millions$ 3,886.750  Millions
Abbvie Inc   5.04 $ 66,014.000  Millions$ 13,100.250  Millions
West Pharmaceutical Services Inc   5.00 $ 3,397.100  Millions$ 680.050  Millions
Aquestive Therapeutics Inc   4.98 $ 48.837  Millions$ 9.803  Millions
Pfizer Inc  4.98 $ 63,625.000  Millions$ 12,785.250  Millions
Omniab Inc   4.88 $ 40.211  Millions$ 8.233  Millions
Mirum Pharmaceuticals Inc   4.81 $ 670.778  Millions$ 139.538  Millions
Bristol myers Squibb Company  4.77 $ 50,033.000  Millions$ 10,493.500  Millions
Bausch and Lomb Corp  4.68 $ 5,418.000  Millions$ 1,158.500  Millions
Orthopediatrics Corp  4.61 $ 263.665  Millions$ 57.191  Millions
Cryo cell International Inc   4.54 $ 31.127  Millions$ 6.851  Millions
Neurocrine Biosciences Inc   4.49 $ 3,701.700  Millions$ 824.800  Millions
Glaukos Corp  4.47 $ 578.355  Millions$ 129.301  Millions
Bioventus Inc   4.46 $ 585.319  Millions$ 131.366  Millions
Eli Lilly And Company  4.41 $ 86,462.000  Millions$ 19,590.250  Millions
Supernus Pharmaceuticals inc   4.35 $ 865.106  Millions$ 199.089  Millions
Stoke Therapeutics Inc   4.32 $ 28.211  Millions$ 6.527  Millions
Dexcom Inc   4.30 $ 5,104.900  Millions$ 1,187.150  Millions
Organon and Co   4.30 $ 6,111.000  Millions$ 1,421.750  Millions
Pro dex Inc   4.27 $ 79.578  Millions$ 18.655  Millions
Alkermes Plc   4.23 $ 1,753.599  Millions$ 414.306  Millions
Medinotec Inc   4.05 $ 10.211  Millions$ 2.524  Millions
Butterfly Network Inc   3.99 $ 123.715  Millions$ 30.972  Millions
Vanda Pharmaceuticals Inc   3.96 $ 229.278  Millions$ 57.866  Millions
Teva Pharmaceutical Industries Limited  3.89 $ 14,020.000  Millions$ 3,608.000  Millions
Bridgebio Pharma Inc   3.88 $ 945.540  Millions$ 243.561  Millions

Date modified: 2026-11-07T10:14:19+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.